Valmark Advisers, Inc. Bristol Myers Squibb CO Transaction History

Valmark Advisers, Inc.

$5.84 Billion
Q2 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	BUY	$47.98 - $54.4 $209,864 - $237,945	4,374 New	4,374 $237,000
Q3 2023 Nov 07, 2023	SELL	$57.89 - $64.73 $8,972 - $10,033	-155 Reduced 3.54%	4,219 $244,000
Q2 2023 Aug 02, 2023	SELL	$63.71 - $70.74 $56,574 - $62,817	-888 Reduced 16.88%	4,374 $279,000
Q1 2023 May 01, 2023	BUY	$65.71 - $74.53 $80,889 - $91,746	1,231 Added 30.54%	5,262 $364,000
Q4 2022 Feb 06, 2023	SELL	$68.48 - $81.09 $21,639 - $25,624	-316 Reduced 7.27%	4,031 $289,000
Q3 2022 Nov 02, 2022	BUY	$0.13 - $76.84 $83 - $49,331	642 Added 17.33%	4,347 $309,000
Q2 2022 Aug 01, 2022	BUY	$72.62 - $79.98 $1,597 - $1,759	22 Added 0.6%	3,705 $285,000
Q1 2022 May 10, 2022	SELL	$61.48 - $73.72 $6,516 - $7,814	-106 Reduced 2.8%	3,683 $269,000
Q4 2021 Feb 02, 2022	SELL	$53.63 - $62.52 $14,748 - $17,193	-275 Reduced 6.77%	3,789 $236,000
Q3 2021 Nov 09, 2021	SELL	$59.17 - $69.31 $81,003 - $94,885	-1,369 Reduced 25.2%	4,064 $240,000
Q2 2021 Aug 06, 2021	SELL	$61.91 - $67.42 $5,633 - $6,135	-91 Reduced 1.65%	5,433 $363,000
Q1 2021 May 04, 2021	SELL	$59.34 - $66.74 $17,267 - $19,421	-291 Reduced 5.0%	5,524 $349,000
Q4 2020 Feb 03, 2021	BUY	$57.74 - $65.43 $42,438 - $48,091	735 Added 14.47%	5,815 $361,000
Q3 2020 Nov 09, 2020	SELL	$57.43 - $63.64 $2,010 - $2,227	-35 Reduced 0.68%	5,080 $306,000
Q2 2020 Jul 31, 2020	SELL	$54.82 - $64.09 $14,746 - $17,240	-269 Reduced 5.0%	5,115 $301,000
Q1 2020 May 01, 2020	SELL	$46.4 - $67.43 $387,254 - $562,770	-8,346 Reduced 60.79%	5,384 $300,000
Q4 2019 Jan 31, 2020	BUY	$49.21 - $64.19 $675,653 - $881,328	13,730 New	13,730 $881,000
Q2 2018 Aug 07, 2018	SELL	$50.53 - $62.98 $161,594 - $201,410	-3,198 Closed	0 $0
Q1 2018 May 07, 2018	BUY	$59.92 - $68.98 $191,624 - $220,598	3,198 New	3,198 $202,000

Others Institutions Holding BMY

# of Institutions

2,425

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

Vanguard Group Inc Valley Forge, PA

187M
Shares

$9.93 Billion
0.15% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$8.44 Billion
0.15% of portfolio
State Street Corp Boston, MA

91.4M
Shares

$4.87 Billion
0.17% of portfolio
Jpmorgan Chase & CO New York, NY

74.6M
Shares

$3.97 Billion
0.27% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

59.1M
Shares

$3.14 Billion
0.47% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Valmark Advisers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Valmark Advisers, Inc. with notifications on news.

Account